Trademark: 97728299
Word
CAIDYA
Status Date
Saturday, August 17, 2024
Filing Date
Thursday, December 22, 2022
Published for Opposition
Tuesday, October 17, 2023
35 Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval; providing independent review of clinical trials for business purposes; Contract research organization (CRO) services, namely, business management in the field of clinical trials, namely, clinical data management
45 Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the pharmaceutical, medical, healthcare, and life sciences fields
42 Contract research organization (CRO) services, namely, monitoring of clinical trials for drugs, biologics and devices of pharmaceutical, medical, healthcare, and life sciences companies for quality control purposes, and clinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areas, in particular gastroenterology, nephrology, urology, and oncology; consulting services in the field of scientific research in the nature of conducting clinical trials in the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, biologics and medical devices; Software as a service (SaaS) services featuring software for accessing, collecting, managing, tracking, analyzing, and reporting data and information on clinical trials; Contract research organization (CRO) services, namely, custom technical writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports; Contract research organization (CRO) services, namely, custom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports for submission to regulatory authorities
The mark consists of the stylized wording "CAIDYA" on the left with the stylized letters "C" and "A" intertwined together to form an infinity symbol, a vertical line in the middle and three Chinese characters on the right.
The non-Latin characters in the mark transliterate to "KANG DI YA" and this has no meaning in a foreign language.
Color is not claimed as a feature of the mark.
The wording "CAIDYA" has no meaning in a foreign language.
Dec 26, 2022
New Application Entered
Jan 19, 2023
New Application Office Supplied Data Entered
Jan 20, 2023
Notice Of Design Search Code E-Mailed
May 19, 2023
Assigned To Examiner
Jun 1, 2023
Non-Final Action Written
Jun 1, 2023
Non-Final Action E-Mailed
Jun 1, 2023
Notification Of Non-Final Action E-Mailed
Sep 1, 2023
Teas Response To Office Action Received
Sep 1, 2023
Correspondence Received In Law Office
Sep 1, 2023
Teas/Email Correspondence Entered
Sep 7, 2023
Examiners Amendment -Written
Sep 7, 2023
Examiners Amendment E-Mailed
Sep 7, 2023
Notification Of Examiners Amendment E-Mailed
Sep 7, 2023
Examiner's Amendment Entered
Sep 7, 2023
Approved For Pub - Principal Register
Oct 17, 2023
Official Gazette Publication Confirmation E-Mailed
Sep 27, 2023
Notification Of Notice Of Publication E-Mailed
Oct 17, 2023
Published For Opposition
Dec 12, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 12, 2024
Teas Statement Of Use Received
Aug 1, 2024
Statement Of Use Processing Complete
Jun 12, 2024
Use Amendment Filed
Aug 1, 2024
Case Assigned To Intent To Use Paralegal
Aug 17, 2024
Su - Non-Final Action - Written
Aug 17, 2024
Notification Of Non-Final Action E-Mailed
Aug 17, 2024
Non-Final Action E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
